CD274 and lung carcinoma: Before PSM, the two groups were comparable in the gender, BMI, smoking index, ECOG score, PDL1 status, TNM stage, immunotherapy line, pathological stage of lung cancer, history of radiotherapy, surgical history, and metastasis sites (all P > 0.05).